Drugs / UCB7853
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04651153 | Dec 2020 → Jul 2023 | Parkinson disease | UCB Biopharma SRL | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UCB7853 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04651153 ↗ |
| Route | Intravenous | “Single intravenous infusion of UCB7853” NCT04651153 ↗ |